HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation

Hikmet F. Nural-Guvener, Luidmila Zakharova, James Nimlos, Snjezana Popovic, Diego Mastroeni, Mohamed A. Gaballa

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint Dive into the research topics of 'HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation'. Together they form a unique fingerprint.

Medicine & Life Sciences